Table 1 |
|
Mechanisms of resistance to sunitinib and everolimus |
|
Potential mechanisms of sunitinib resistance |
|
|
|
Hypoxia resistance of RCC cells |
|
Vascular resistance to VEGFR and PDGFR inhibition by sunitinib |
|
Potential mechanisms of everolimus resistance |
|
Resistance of RCC cells to direct anti-proliferative everolimus effects |
|
Resistance of HIF1α target gene expression to repression by everolimus |
|
Hypoxia resistance of RCC cells |
|
Vascular resistance to VEGF pathway inhibition |
|
|
|
PDGFR, platelet derived growth factor receptor; RCC, renal cell carcinoma; VEGF, vascular endothelial growth factor; VEGFR, VEGF receptor. |
|
Swanton et al. Genome Med 2010 2:53 doi:10.1186/gm174 |